rts logo

Why Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock Could See Much Higher Prices Ahead

Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is 58.91% higher on its value in year-to-date trading and has touched a low of $7.09 and a high of $17.13 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TEVA stock was last observed hovering at around $16.81 in the last trading session, with the day’s loss setting it -0.22%.

Currently trading at $16.59, the stock is 10.81% and 17.05% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.43 million and changing -1.31% at the moment leaves the stock 46.20% off its SMA200. TEVA registered 109.73% gain for a year compared to 6-month gain of 83.31%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 28.80% loss in the last 1 month and extending the period to 3 months gives it a 27.62%, and is -2.93% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.60% over the week and 3.16% over the month.

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 37226 employees, a market worth around $18.60B and $16.02B in sales. Fwd P/E is 6.14. Profit margin for the company is -2.88%. Distance from 52-week low is 134.16% and -3.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.91%).

The EPS is expected to shrink by -4.95% this year.

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Top Institutional Holders

The shares outstanding are 1.12B, and float is at 1.12B with Short Float at 1.09%.

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity

The most recent transaction is an insider sale by Weiss Amir,the company’sChief Accounting Officer. SEC filings show that Weiss Amir sold 12,635 shares of the company’s common stock on May 16 ’24 at a price of $16.65 per share for a total of $0.21 million. Following the sale, the insider now owns 5179.0 shares.

Teva- Pharmaceutical Industries Ltd. ADR disclosed in a document filed with the SEC on May 15 ’24 that Weiss Amir (Chief Accounting Officer) sold a total of 15,500 shares of the company’s common stock. The trade occurred on May 15 ’24 and was made at $16.80 per share for $0.26 million. Following the transaction, the insider now directly holds 17814.0 shares of the TEVA stock.

Still, SEC filings show that on May 13 ’24, Conway Vikki L. disposed off 15,219 shares at an average price of $16.74 for $0.25 million. The insider now directly holds 0 shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).

Related Posts